ArticleBlood cancer journal2021

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.

Jean Galtier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.